Newsroom

Press Releases

Saniona Icon blue
June 30, 2021
PRESS RELEASE June 30 , 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it has dosed the first patient in a P hase 1 clinical trial of SAN711, a novel molecule derived from Saniona’s proprietary ion channel drug discovery engine.
June 25, 2021
PRESS RELEASE June 25 , 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that its partner Productos Medix , S.A de S.V, (Medix) has provided Saniona with an update on the Mexican regulatory authority Comisión Federal para la Protección
May 26, 2021
PRESS RELEASE May 2 6 , 2021 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders in Saniona AB, Reg. No. 556962-5345, are hereby invited to the extraordinary shareholders’
May 26, 2021
PRESS RELEASE May 26 , 202 1 Q1 202 1 ( Q1 20 20 ) Revenue was SEK 3.4 M (2.4 M) Operating loss was SEK -94.1 (-27.4 M) Net profit/loss was SEK -83.4 M (43.2 M) Earnings per share were SEK -1.34 (1.47) Diluted earnings per share were SEK -1.34 (1.47) Business highlights in Q 1 2021 The U.S.
Displaying 11 - 20 of 41